SRTD biotech

Biotechnology

Overview

Technology Pipeline News Team Contact seRNA building blocks seRNA building blocks An RNA pro-drug platform technology that can easily be adapted seRNAs represent a pro-drug platform technology that can easily be adapted to numerous therapeutic areas by utilizing the transcriptome for selective cell targeting and proprietary fLNPs for organ specific pre-targeting.

Funding and backers

Team
11-50
employees, estimated range
Backers
1
High-Tech Gründerfonds
Momentum
0/100
no fresh signals
Registers and programsofficial lists and records that name the company
Legal entity Impress SRTD Biotech GmbH its site
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
光粒,光粒科技,AR智能泳镜,智能泳镜,AR泳镜,泳镜,游泳镜,游泳眼镜,Holosport,holosport,Holoswim,holoswim,Holoswim2s,holoswim2s,Holoswim 2 Pro,holoswim 2 Pro,#更智能更健康.
Kailash Labs is a video research and product lab. We are on a mission to convert the world's videos into structured data that machines can…
Refoxy Pharmaceuticals GmbH is a pre-clinical biotech company developing FOXO3-targeting therapies to restore cellular balance and treat…
Akribion TherapeuticsVenture round · 2 yr ago · Founded 2024
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Founded in 2024 and…
synendosSeries A $22.4M · 5 yr ago · 51-200 employees
Synendos Therapeutics advances selective endocannabinoid reuptake inhibitors to restore ECS balance, developing new treatments for anxiety…
TECHNOLOGY M20 Seq Single-Cell Transcriptome M20 Spatial Spatial Transcriptome PRODUCTS Single-Cell Transcriptome for FFPE Samples…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
516 portfolio companies